Related Experiment Videos
Total respiratory system compliance in asymptomatic infants with cystic fibrosis
Insights
Total respiratory system compliance (Crs) measurement effectively detects early lung function changes in infants with cystic fibrosis (CF). This noninvasive method identifies abnormalities before they become apparent on chest radiographs.
Area of Science:
- Pediatric Pulmonology
- Respiratory Physiology
Background:
- Cystic Fibrosis (CF) is a genetic disorder affecting multiple organs, primarily the lungs.
- Early detection of pulmonary dysfunction in infants with CF is crucial for timely intervention.
- Standard chest radiographs may not reveal subtle early lung changes in infants with CF.
Purpose of the Study:
- To assess total respiratory system compliance (Crs) in asymptomatic infants with CF.
- To identify noninvasive pulmonary function parameters that can distinguish infants with CF from healthy controls.
- To evaluate the utility of Crs measurement for early detection of pulmonary abnormalities in CF.
Main Methods:
- Total respiratory system compliance (Crs) was measured using a weighted spirometer method.
- Functional residual capacity (FRC), respiratory rate (RR), and mixing index (MI) were also assessed.
- A cohort of 11 asymptomatic infants with CF (mean age 11.1 months) was compared to 36 healthy controls.
Main Results:
- Infants with CF exhibited significantly lower Crs (5.7 +/- 2.8 ml/cm H2O) compared to controls (9.0 +/- 3.4 ml/cm H2O).
- Specific compliance (Crs/FRC) was also markedly reduced in the CF group (0.029 +/- 0.007 1/cm H2O vs. 0.049 +/- 0.013 1/cm H2O).
- While FRC showed no significant difference, CF infants had higher RR and lower MI, indicating abnormal ventilation distribution.
Conclusions:
- Measurement of Crs is a sensitive, noninvasive method for detecting early pulmonary function abnormalities in infants with cystic fibrosis.
- Reduced Crs and specific compliance are key indicators distinguishing infants with CF.
- These findings support the use of Crs assessment in the early diagnostic pathway for pediatric CF.
Abstract:
Total respiratory system compliance (Crs) was assessed by the weighted spirometer method in 11 asymptomatic infants (mean age, 11.1 months) with cystic fibrosis (CF) who had normal chest radiographs. In addition to Crs, functional residual capacity (FRC), respiratory rate (RR), and mixing index (MI) were measured. There was no significant difference in FRC between normal controls (n = 36) and CF infants (190 +/- 69 versus 186 +/- 63 ml; p less than 0.8), although the CF group had a higher RR (32 +/- 7 versus 37 +/- 7 BPM; p less than 0.05) and a lower MI (45 +/- 7 versus 40 +/- 8%; p less than 0.05), reflecting an abnormal distribution of ventilation. The lower Crs (9.0 +/- 3.4 versus 5.7 +/- 2.8 ml/cm H2O; p less than 0.01) and the lower specific compliance, Crs/FRC (0.049 +/- 0.013 versus 0.029 +/- 0.007 1/cm H2O; p less than 0.0001), in the CF group were the parameters that best distinguished the normal control and CF infants. We conclude that the measurement of Crs represents a noninvasive method for detecting early pulmonary function abnormalities in CF infants.